This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Conferences
Recent Abstracts
Interventional radiology: Potential breakthrough to treat men’s enlarged prostate
May 2, 2012
SIR 2012 - Relevant angiographic findings during prostatic arterial embolization for the treatment of benign prostatic hyperplasia - Session Abstract
May 2, 2012
SIR 2012 - Further evaluation of prostatic artery embolization of symptomatic benign prostatic hyperplasia in a large series of patients. Safety, short, and medium term outcomes - Session Abstract
May 2, 2012
SIR 2012 - Quality of life and symptoms relief support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia - Session Abstract
May 2, 2012
EAU 2012 - Comparison of two different Botulinumtoxin A products (Xeomin, Botox) used for detrusor injection in patients with bladder overactivity (BO) – a prospective randomized double-blind study - Session Highlights
March 30, 2012
EAU 2012 - Neuro-urological practice in spinal injuries units in UK and Eire and EAU Neurogenic Lower Urinary Tract Dysfunction guidelines - Session Highlights
March 30, 2012
EAU 2012 - The β3-adrenoceptor agonist Solabegron is safe and effective for improving symptoms of overactive bladder - Session Highlights
March 30, 2012
EAU 2012 - Ulcerative and non-ulcerative forms of bladder pain syndrome/IC do not differ in the intensity of LUTS and respond similarly to intra-trigonal Onabotulinum type A injections - Session Highlights
March 30, 2012
EAU 2012 - A randomized controlled trial to evaluate the efficacy of botulinum toxin type A in the treatment of patients suffering bladder pain syndrome/interstitial cystitis with Hunner’s lesions: Preliminary results - Session Highlights
March 30, 2012
EAU 2012 - The role of Permixon therapy for category II/III chronic prostatitis: A prospective two-year study - Session Highlights
March 30, 2012
EAU 2012 - Health-related quality of life in patients with overactive bladder - Session Highlights
March 30, 2012
EAU 2012 - Effect of treatment response on the decision to escalate antimuscarinic dose in elderly subjects with overactive bladder - Session Highlights
March 30, 2012
EAU 2012 - Prevalence and clinical features of detrusor underactivity among the community-dwelling elderly with lower urinary tract symptoms: A comparison between men and women - Session Highlights
March 30, 2012
EAU 2012 - The efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by multiple sclerosis: Long term follow up - Session Highlights
March 30, 2012
EAU 2012 - Value of nerve growth factor levels in overactive bladder syndrome – alterations after botulinum toxin therapy - Session Highlights
March 30, 2012
EAU 2012 - The β3-adrenoceptor agonist Solabegron is safe and effective for improving symptoms of overactive bladder - Poster
March 30, 2012
EAU 2012 - Spontaneous contractile activity of human neurogenic bladder strips: Can we predict a correlation between clinical factors, urodynamics and histological features? - Session Highlights
March 30, 2012
EAU 2012 - Urethral versus suprapubic catheter for patients with spinal cord injury induced neurogenic bladder: A study applying the eleven-year comprehensive nationwide database of Taiwan - Session Highlights
March 30, 2012
EAU 2012 - The key role of time in predicting post-radical prostatectomy urinary continence recovery rate: Conditional survival analysis - Session Highlights
March 30, 2012
EAU 2012 - Dynamics of the pelvic floor in continent and stress urinary incontinent men after radical prostatectomy: A functional MRI study - Session Highlights
March 30, 2012
Page 578 of 594
Start
Prev
573
574
575
576
577
578
579
580
581
582
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free